![Amarpreet S. Sawhney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amarpreet S. Sawhney
Gründer bei
Incept LLC
Profil
Amarpreet S.
Sawhney was the founder of Focal, Inc. (1992) serving as Director from 1992 to 1998; Confluent Surgical, Inc. (1998) serving as President & Chief Executive Officer; Incept LLC (1998) serving as General Partner since 2011; Access Closure, Inc. (2001) serving as Director; Ocular Therapeutix, Inc. (2006) serving as Executive Chairman from 2017 to 2019; Augmenix, Inc. (2008) serving as Chairman from 2014 to 2018; StataDX, Inc. (2021) serving as Director since 2021; and Instylla, Inc. (2017) serving as Chairman starting 2025.
Current jobs include Chairman at Rejoni, Inc., Director at Axtria, Inc., and Principal at TiE Boston.
Former jobs include Director at SquareOne, Inc., marketRx LLC, and Ostial Corp.
Education includes undergraduate degree from Indian Institute of Technology New Delhi and graduate and doctorate degrees from The University of Texas at Austin.
Aktive Positionen von Amarpreet S. Sawhney
| Unternehmen | Position | Beginn |
|---|---|---|
Axtria, Inc.
 Axtria, Inc. Packaged SoftwareTechnology Services Develops agentic AI-based data analytics software | Direktor/Vorstandsmitglied | 11.05.2010 |
Incept LLC
 Incept LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnical research company | Gründer | 01.01.1998 |
TiE Boston
 TiE Boston Investment ManagersFinance TiE Boston seeks investment opportunities in companies located in the United States. The firm targets companies operating in a variety of sectors. | Corporate Officer/Principal | 13.06.2011 |
Instylla, Inc.
 Instylla, Inc. Medical SpecialtiesHealth Technology Develops liquid embolics agents for interventional radiology, with an initial focus on treating hyper vascular tumors | Gründer | 01.01.2017 |
Rejoni, Inc.
 Rejoni, Inc. BiotechnologyHealth Technology Provides clinical trial services for uterine surgery | Vorsitzender | - |
Statadx, Inc.
 Statadx, Inc. Packaged SoftwareTechnology Services Develops e-rapid sensor technology platform that designed to implement custom biomarker panels for clinical studies | Gründer | 01.01.2021 |
Ehemalige bekannte Positionen von Amarpreet S. Sawhney
| Unternehmen | Position | Ende |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Vorstandsvorsitzender | 26.07.2017 |
Augmenix, Inc.
 Augmenix, Inc. Medical SpecialtiesHealth Technology Develops hydrogel technology to improve outcomes in radiation oncology and surgery | Vorstandsvorsitzender | 01.04.2014 |
Access Closure, Inc.
 Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States | Gründer | 01.05.2009 |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Amarpreet S. Sawhney
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Focal, Inc.
 Focal, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures synthetic liquid surgical sealant | Process Industries |
Access Closure, Inc.
Access Closure, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes the vascular closure devices in the United States | Health Technology |
Confluent Surgical, Inc.
 Confluent Surgical, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
SquareOne, Inc.
 SquareOne, Inc. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Augmenix, Inc.
Augmenix, Inc. Medical SpecialtiesHealth Technology Develops hydrogel technology to improve outcomes in radiation oncology and surgery | Health Technology |
Axtria, Inc.
Axtria, Inc. Packaged SoftwareTechnology Services Develops agentic AI-based data analytics software | Technology Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indian Institute of Technology New Delhi
 Indian Institute of Technology New Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
marketRx LLC
 marketRx LLC Miscellaneous Commercial ServicesCommercial Services Provides marketing research and technology consulting services | Commercial Services |
TiE Boston
TiE Boston Investment ManagersFinance TiE Boston seeks investment opportunities in companies located in the United States. The firm targets companies operating in a variety of sectors. | Finance |
Ostial Corp.
 Ostial Corp. Medical/Nursing ServicesHealth Services Develops catheter-based delivery system combined with a bare metal stent | Health Services |
Incept LLC
Incept LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnical research company | Commercial Services |
Instylla, Inc.
Instylla, Inc. Medical SpecialtiesHealth Technology Develops liquid embolics agents for interventional radiology, with an initial focus on treating hyper vascular tumors | Health Technology |
Rejoni, Inc.
Rejoni, Inc. BiotechnologyHealth Technology Provides clinical trial services for uterine surgery | Health Technology |
Statadx, Inc.
Statadx, Inc. Packaged SoftwareTechnology Services Develops e-rapid sensor technology platform that designed to implement custom biomarker panels for clinical studies | Technology Services |
